Vitaspring Biomedical VSBC
OTC VSBC
$0.01 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Vitaspring Biomedical (VSBC) Selling, General & Administrative (2017 - 2026)

Updated

Vitaspring Biomedical's Selling, General & Administrative was $5,830 in fiscal Q2 2027 (quarter ended Jul 31, 2026), down 3.7% from $6,054 a year earlier and down 92.3% from the prior quarter.

Analysis

Vitaspring Biomedical (VSBC) Selling, General & Administrative (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vitaspring Biomedical's Selling, General & Administrative was $298,871 through Jul 31, 2026, down 6.5% year-over-year; for FY2026 (ended Jan 31, 2026), it came in at $385,411, down 43.3% from FY2025.

  • Selling, General & Administrative shows a five-year compound annual growth rate of -6.4% (FY2021 to FY2026).
  • In earlier fiscal years, Selling, General & Administrative was $679,914 in FY2025 (-39.2%), $1.12 million in FY2024 (+32.4%), $844,836 in FY2023 (-10.3%) and $941,336 in FY2022 (+75.1%).
  • The fiscal Q2 2027 figure marks the lowest quarterly Selling, General & Administrative since fiscal Q4 2020.
  • Compared with a year earlier, Selling, General & Administrative was higher in two of the last eight quarters, with an average decline of 34.2%.
  • The best year-over-year quarter for Selling, General & Administrative over five years was fiscal Q3 2022 (growth of 395.3%); the worst was fiscal Q2 2026 (a decline of 97.2%).
  • Per Business Quant data, VSBC's Selling, General & Administrative in the three fiscal quarters before Q2 2027 was $75,844 (Q1 2027), $81,464 (Q4 2026) and $135,733 (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.43 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.63 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.90 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -3.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -5.65 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.75 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.92 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 3.41 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 582.20 Mn
10 Vitaspring Biomedical 2.07 Mn 2.04 Mn - 5,830.00
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 5,830.00
Apr 30, 2026 75,844.00
Jan 31, 2026 81,464.00
Oct 31, 2025 135,733.00
Jul 31, 2025 6,054.00
Apr 30, 2025 69,147.00
Jan 31, 2025 126,494.00
Oct 31, 2024 117,927.00
Jul 31, 2024 218,662.00
Apr 30, 2024 216,831.00
Jan 31, 2024 225,398.00
Oct 31, 2023 234,980.00
Jul 31, 2023 353,583.00
Apr 30, 2023 304,601.00
Jan 31, 2023 262,233.00
Oct 31, 2022 183,219.00
Jul 31, 2022 174,511.00
Apr 30, 2022 224,873.00
Jan 31, 2022 633,170.00
Oct 31, 2021 157,453.00
API Access

Vitaspring Biomedical Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=VSBC&period=max&api_key=YOUR_API_KEY